* 由恒瑞医药600276.SS董事长孙飘扬之妻女控股的中国翰森制药3692.HK周五早盘高开2.1%，目前涨幅收窄。
* 该公司此前公告称，阿美乐（甲磺酸阿美替尼片）第五项适应症获国家药品监督管理局签发药品注册证书，该适应症为阿美乐联合培美曲塞和铂类化疗药物适用于具有表皮生长因子受体外显子19缺失或外显子21(L858R)置换突变的局部晚期或转移性非小细胞肺癌成人患者的一线治疗。
* 恒⽣⽣物科技指数.HSBIO盘中一度跌1.4%。（完）
更多股市简讯请点选CN-CMN-HOT
(发稿 徐凯文；审校 吴云凌)
((kaiwen.xu@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.